Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface

Broadly reactive antibodies targeting the influenza A virus hemagglutinin (HA) head domain are thought to be rare and to require extensive somatic mutations or unusual structural features to achieve breadth against divergent HA subtypes. Here we describe common genetic and structural features of pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2021-08, Vol.131 (15), p.1-11
Hauptverfasser: Zost, Seth J, Dong, Jinhui, Gilchuk, Iuliia M, Gilchuk, Pavlo, Thornburg, Natalie J, Bangaru, Sandhya, Kose, Nurgun, Finn, Jessica A, Bombardi, Robin, Soto, Cinque, Chen, Elaine C, Nargi, Rachel S, Sutton, Rachel E, Irving, Ryan P, Suryadevara, Naveenchandra, Westover, Jonna B, Carnahan, Robert H, Turner, Hannah L, Li, Sheng, Ward, Andrew B, Crowe, Jr, James E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11
container_issue 15
container_start_page 1
container_title The Journal of clinical investigation
container_volume 131
creator Zost, Seth J
Dong, Jinhui
Gilchuk, Iuliia M
Gilchuk, Pavlo
Thornburg, Natalie J
Bangaru, Sandhya
Kose, Nurgun
Finn, Jessica A
Bombardi, Robin
Soto, Cinque
Chen, Elaine C
Nargi, Rachel S
Sutton, Rachel E
Irving, Ryan P
Suryadevara, Naveenchandra
Westover, Jonna B
Carnahan, Robert H
Turner, Hannah L
Li, Sheng
Ward, Andrew B
Crowe, Jr, James E
description Broadly reactive antibodies targeting the influenza A virus hemagglutinin (HA) head domain are thought to be rare and to require extensive somatic mutations or unusual structural features to achieve breadth against divergent HA subtypes. Here we describe common genetic and structural features of protective human antibodies from several individuals recognizing the trimer interface (TI) of the influenza A HA head, a recently identified site of vulnerability. We examined the sequence of TI-reactive antibodies, determined crystal structures for TI antibody-antigen complexes, and analyzed the contact residues of the antibodies on HA to discover common genetic and structural features of TI antibodies. Our data reveal that many TI antibodies are encoded by a light chain variable gene segment incorporating a shared somatic mutation. In addition, these antibodies have a shared acidic residue in the heavy chain despite originating from diverse heavy chain variable gene segments. These studies show that the TI region of influenza A HA is a major antigenic site with conserved structural features that are recognized by a common human B cell public clonotype. The canonical nature of this antibody-antigen interaction suggests that the TI epitope might serve as an important target for structure-based vaccine design.
doi_str_mv 10.1172/JCI146791
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8321569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A677389416</galeid><sourcerecordid>A677389416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c647t-fa2815fd806b16c0ec4475ba6f36d1438475bbc74a9c7d11592a1961e97c61613</originalsourceid><addsrcrecordid>eNqNkluL1TAQx4so7rr64BeQgiD60LVpc2lfhOXg5cjCgrfXME0nbZY2WZNUdD-9Ka6Hc-Q8SAJJJr_5ZzIzWfaUlOeEiOr1x82WUC5aci87JYw1RVPVzf29_Un2KITrsiSUMvowO6kpYbwV9DSTG7DOGgVTrhHi4jHkTufjMoPNwUbTud4km0flBmtujR3yOGJurJ4WtLeQjzjDMExLNNbYPHozo0_XEb0GhY-zBxqmgE_u1rPs67u3XzYfisur99vNxWWhOBWx0FA1hOm-KXlHuCpRUSpYB1zXvCe0btZTpwSFVomeENZWQFpOsBWKE07qs-zNH92bpZuxV2ijh0nepHDA_5IOjDy8sWaUg_shm7pac5EEXt4JePd9wRDlbILCaQKLbgmyYjQlr6naOqHP_0Gv3eJt-l6imEiT8z1qgAllypdL76pVVF5wIeqmpYQnqjhCDWgxBeksapPMB_z5ET6NHmejjjq8OnBITMSfcYAlBLn9_On_2atvh-yLPXZEmOIY3NoGzoajosq7EDzqXVFIKdf2lbv2Teyz_SruyL_9Wv8GdCPnHw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2557557663</pqid></control><display><type>article</type><title>Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Zost, Seth J ; Dong, Jinhui ; Gilchuk, Iuliia M ; Gilchuk, Pavlo ; Thornburg, Natalie J ; Bangaru, Sandhya ; Kose, Nurgun ; Finn, Jessica A ; Bombardi, Robin ; Soto, Cinque ; Chen, Elaine C ; Nargi, Rachel S ; Sutton, Rachel E ; Irving, Ryan P ; Suryadevara, Naveenchandra ; Westover, Jonna B ; Carnahan, Robert H ; Turner, Hannah L ; Li, Sheng ; Ward, Andrew B ; Crowe, Jr, James E</creator><creatorcontrib>Zost, Seth J ; Dong, Jinhui ; Gilchuk, Iuliia M ; Gilchuk, Pavlo ; Thornburg, Natalie J ; Bangaru, Sandhya ; Kose, Nurgun ; Finn, Jessica A ; Bombardi, Robin ; Soto, Cinque ; Chen, Elaine C ; Nargi, Rachel S ; Sutton, Rachel E ; Irving, Ryan P ; Suryadevara, Naveenchandra ; Westover, Jonna B ; Carnahan, Robert H ; Turner, Hannah L ; Li, Sheng ; Ward, Andrew B ; Crowe, Jr, James E</creatorcontrib><description>Broadly reactive antibodies targeting the influenza A virus hemagglutinin (HA) head domain are thought to be rare and to require extensive somatic mutations or unusual structural features to achieve breadth against divergent HA subtypes. Here we describe common genetic and structural features of protective human antibodies from several individuals recognizing the trimer interface (TI) of the influenza A HA head, a recently identified site of vulnerability. We examined the sequence of TI-reactive antibodies, determined crystal structures for TI antibody-antigen complexes, and analyzed the contact residues of the antibodies on HA to discover common genetic and structural features of TI antibodies. Our data reveal that many TI antibodies are encoded by a light chain variable gene segment incorporating a shared somatic mutation. In addition, these antibodies have a shared acidic residue in the heavy chain despite originating from diverse heavy chain variable gene segments. These studies show that the TI region of influenza A HA is a major antigenic site with conserved structural features that are recognized by a common human B cell public clonotype. The canonical nature of this antibody-antigen interaction suggests that the TI epitope might serve as an important target for structure-based vaccine design.</description><identifier>ISSN: 1558-8238</identifier><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI146791</identifier><identifier>PMID: 34156974</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Antibodies ; Antibodies, Neutralizing - chemistry ; Antibodies, Neutralizing - immunology ; Antibodies, Viral - chemistry ; Antibodies, Viral - immunology ; Antigen-antibody reactions ; Antigens ; Avian flu ; Biomedical research ; Development and progression ; Epitopes ; Epitopes - chemistry ; Epitopes - immunology ; Genetic aspects ; Genetic diversity ; Glycoproteins ; Health aspects ; Hemagglutinin Glycoproteins, Influenza Virus - chemistry ; Hemagglutinin Glycoproteins, Influenza Virus - immunology ; Hemagglutinins ; Humans ; Immunization ; Immunological research ; Influenza ; Influenza A ; Influenza A Virus, H1N1 Subtype - chemistry ; Influenza A Virus, H1N1 Subtype - immunology ; Influenza vaccines ; Influenza Vaccines - chemistry ; Influenza Vaccines - immunology ; Mutation ; Peptides ; Prevention ; Structure ; Trimers ; Vaccines ; Viral antibodies ; Viral proteins ; Viruses</subject><ispartof>The Journal of clinical investigation, 2021-08, Vol.131 (15), p.1-11</ispartof><rights>COPYRIGHT 2021 American Society for Clinical Investigation</rights><rights>Copyright American Society for Clinical Investigation Aug 2021</rights><rights>2021 American Society for Clinical Investigation 2021 American Society for Clinical Investigation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c647t-fa2815fd806b16c0ec4475ba6f36d1438475bbc74a9c7d11592a1961e97c61613</citedby><cites>FETCH-LOGICAL-c647t-fa2815fd806b16c0ec4475ba6f36d1438475bbc74a9c7d11592a1961e97c61613</cites><orcidid>0000-0003-3523-3616 ; 0000-0002-3642-2980 ; 0000-0002-4745-8057 ; 0000-0001-7153-3769 ; 0000-0003-2571-1290 ; 0000-0001-6712-5076 ; 0000-0001-7883-8039 ; 0000-0002-9073-6809 ; 0000-0003-4542-7756 ; 0000-0002-0049-1079</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321569/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321569/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34156974$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zost, Seth J</creatorcontrib><creatorcontrib>Dong, Jinhui</creatorcontrib><creatorcontrib>Gilchuk, Iuliia M</creatorcontrib><creatorcontrib>Gilchuk, Pavlo</creatorcontrib><creatorcontrib>Thornburg, Natalie J</creatorcontrib><creatorcontrib>Bangaru, Sandhya</creatorcontrib><creatorcontrib>Kose, Nurgun</creatorcontrib><creatorcontrib>Finn, Jessica A</creatorcontrib><creatorcontrib>Bombardi, Robin</creatorcontrib><creatorcontrib>Soto, Cinque</creatorcontrib><creatorcontrib>Chen, Elaine C</creatorcontrib><creatorcontrib>Nargi, Rachel S</creatorcontrib><creatorcontrib>Sutton, Rachel E</creatorcontrib><creatorcontrib>Irving, Ryan P</creatorcontrib><creatorcontrib>Suryadevara, Naveenchandra</creatorcontrib><creatorcontrib>Westover, Jonna B</creatorcontrib><creatorcontrib>Carnahan, Robert H</creatorcontrib><creatorcontrib>Turner, Hannah L</creatorcontrib><creatorcontrib>Li, Sheng</creatorcontrib><creatorcontrib>Ward, Andrew B</creatorcontrib><creatorcontrib>Crowe, Jr, James E</creatorcontrib><title>Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Broadly reactive antibodies targeting the influenza A virus hemagglutinin (HA) head domain are thought to be rare and to require extensive somatic mutations or unusual structural features to achieve breadth against divergent HA subtypes. Here we describe common genetic and structural features of protective human antibodies from several individuals recognizing the trimer interface (TI) of the influenza A HA head, a recently identified site of vulnerability. We examined the sequence of TI-reactive antibodies, determined crystal structures for TI antibody-antigen complexes, and analyzed the contact residues of the antibodies on HA to discover common genetic and structural features of TI antibodies. Our data reveal that many TI antibodies are encoded by a light chain variable gene segment incorporating a shared somatic mutation. In addition, these antibodies have a shared acidic residue in the heavy chain despite originating from diverse heavy chain variable gene segments. These studies show that the TI region of influenza A HA is a major antigenic site with conserved structural features that are recognized by a common human B cell public clonotype. The canonical nature of this antibody-antigen interaction suggests that the TI epitope might serve as an important target for structure-based vaccine design.</description><subject>Antibodies</subject><subject>Antibodies, Neutralizing - chemistry</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antibodies, Viral - chemistry</subject><subject>Antibodies, Viral - immunology</subject><subject>Antigen-antibody reactions</subject><subject>Antigens</subject><subject>Avian flu</subject><subject>Biomedical research</subject><subject>Development and progression</subject><subject>Epitopes</subject><subject>Epitopes - chemistry</subject><subject>Epitopes - immunology</subject><subject>Genetic aspects</subject><subject>Genetic diversity</subject><subject>Glycoproteins</subject><subject>Health aspects</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - chemistry</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - immunology</subject><subject>Hemagglutinins</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunological research</subject><subject>Influenza</subject><subject>Influenza A</subject><subject>Influenza A Virus, H1N1 Subtype - chemistry</subject><subject>Influenza A Virus, H1N1 Subtype - immunology</subject><subject>Influenza vaccines</subject><subject>Influenza Vaccines - chemistry</subject><subject>Influenza Vaccines - immunology</subject><subject>Mutation</subject><subject>Peptides</subject><subject>Prevention</subject><subject>Structure</subject><subject>Trimers</subject><subject>Vaccines</subject><subject>Viral antibodies</subject><subject>Viral proteins</subject><subject>Viruses</subject><issn>1558-8238</issn><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkluL1TAQx4so7rr64BeQgiD60LVpc2lfhOXg5cjCgrfXME0nbZY2WZNUdD-9Ka6Hc-Q8SAJJJr_5ZzIzWfaUlOeEiOr1x82WUC5aci87JYw1RVPVzf29_Un2KITrsiSUMvowO6kpYbwV9DSTG7DOGgVTrhHi4jHkTufjMoPNwUbTud4km0flBmtujR3yOGJurJ4WtLeQjzjDMExLNNbYPHozo0_XEb0GhY-zBxqmgE_u1rPs67u3XzYfisur99vNxWWhOBWx0FA1hOm-KXlHuCpRUSpYB1zXvCe0btZTpwSFVomeENZWQFpOsBWKE07qs-zNH92bpZuxV2ijh0nepHDA_5IOjDy8sWaUg_shm7pac5EEXt4JePd9wRDlbILCaQKLbgmyYjQlr6naOqHP_0Gv3eJt-l6imEiT8z1qgAllypdL76pVVF5wIeqmpYQnqjhCDWgxBeksapPMB_z5ET6NHmejjjq8OnBITMSfcYAlBLn9_On_2atvh-yLPXZEmOIY3NoGzoajosq7EDzqXVFIKdf2lbv2Teyz_SruyL_9Wv8GdCPnHw</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Zost, Seth J</creator><creator>Dong, Jinhui</creator><creator>Gilchuk, Iuliia M</creator><creator>Gilchuk, Pavlo</creator><creator>Thornburg, Natalie J</creator><creator>Bangaru, Sandhya</creator><creator>Kose, Nurgun</creator><creator>Finn, Jessica A</creator><creator>Bombardi, Robin</creator><creator>Soto, Cinque</creator><creator>Chen, Elaine C</creator><creator>Nargi, Rachel S</creator><creator>Sutton, Rachel E</creator><creator>Irving, Ryan P</creator><creator>Suryadevara, Naveenchandra</creator><creator>Westover, Jonna B</creator><creator>Carnahan, Robert H</creator><creator>Turner, Hannah L</creator><creator>Li, Sheng</creator><creator>Ward, Andrew B</creator><creator>Crowe, Jr, James E</creator><general>American Society for Clinical Investigation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3523-3616</orcidid><orcidid>https://orcid.org/0000-0002-3642-2980</orcidid><orcidid>https://orcid.org/0000-0002-4745-8057</orcidid><orcidid>https://orcid.org/0000-0001-7153-3769</orcidid><orcidid>https://orcid.org/0000-0003-2571-1290</orcidid><orcidid>https://orcid.org/0000-0001-6712-5076</orcidid><orcidid>https://orcid.org/0000-0001-7883-8039</orcidid><orcidid>https://orcid.org/0000-0002-9073-6809</orcidid><orcidid>https://orcid.org/0000-0003-4542-7756</orcidid><orcidid>https://orcid.org/0000-0002-0049-1079</orcidid></search><sort><creationdate>20210801</creationdate><title>Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface</title><author>Zost, Seth J ; Dong, Jinhui ; Gilchuk, Iuliia M ; Gilchuk, Pavlo ; Thornburg, Natalie J ; Bangaru, Sandhya ; Kose, Nurgun ; Finn, Jessica A ; Bombardi, Robin ; Soto, Cinque ; Chen, Elaine C ; Nargi, Rachel S ; Sutton, Rachel E ; Irving, Ryan P ; Suryadevara, Naveenchandra ; Westover, Jonna B ; Carnahan, Robert H ; Turner, Hannah L ; Li, Sheng ; Ward, Andrew B ; Crowe, Jr, James E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c647t-fa2815fd806b16c0ec4475ba6f36d1438475bbc74a9c7d11592a1961e97c61613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies</topic><topic>Antibodies, Neutralizing - chemistry</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antibodies, Viral - chemistry</topic><topic>Antibodies, Viral - immunology</topic><topic>Antigen-antibody reactions</topic><topic>Antigens</topic><topic>Avian flu</topic><topic>Biomedical research</topic><topic>Development and progression</topic><topic>Epitopes</topic><topic>Epitopes - chemistry</topic><topic>Epitopes - immunology</topic><topic>Genetic aspects</topic><topic>Genetic diversity</topic><topic>Glycoproteins</topic><topic>Health aspects</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - chemistry</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - immunology</topic><topic>Hemagglutinins</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunological research</topic><topic>Influenza</topic><topic>Influenza A</topic><topic>Influenza A Virus, H1N1 Subtype - chemistry</topic><topic>Influenza A Virus, H1N1 Subtype - immunology</topic><topic>Influenza vaccines</topic><topic>Influenza Vaccines - chemistry</topic><topic>Influenza Vaccines - immunology</topic><topic>Mutation</topic><topic>Peptides</topic><topic>Prevention</topic><topic>Structure</topic><topic>Trimers</topic><topic>Vaccines</topic><topic>Viral antibodies</topic><topic>Viral proteins</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zost, Seth J</creatorcontrib><creatorcontrib>Dong, Jinhui</creatorcontrib><creatorcontrib>Gilchuk, Iuliia M</creatorcontrib><creatorcontrib>Gilchuk, Pavlo</creatorcontrib><creatorcontrib>Thornburg, Natalie J</creatorcontrib><creatorcontrib>Bangaru, Sandhya</creatorcontrib><creatorcontrib>Kose, Nurgun</creatorcontrib><creatorcontrib>Finn, Jessica A</creatorcontrib><creatorcontrib>Bombardi, Robin</creatorcontrib><creatorcontrib>Soto, Cinque</creatorcontrib><creatorcontrib>Chen, Elaine C</creatorcontrib><creatorcontrib>Nargi, Rachel S</creatorcontrib><creatorcontrib>Sutton, Rachel E</creatorcontrib><creatorcontrib>Irving, Ryan P</creatorcontrib><creatorcontrib>Suryadevara, Naveenchandra</creatorcontrib><creatorcontrib>Westover, Jonna B</creatorcontrib><creatorcontrib>Carnahan, Robert H</creatorcontrib><creatorcontrib>Turner, Hannah L</creatorcontrib><creatorcontrib>Li, Sheng</creatorcontrib><creatorcontrib>Ward, Andrew B</creatorcontrib><creatorcontrib>Crowe, Jr, James E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zost, Seth J</au><au>Dong, Jinhui</au><au>Gilchuk, Iuliia M</au><au>Gilchuk, Pavlo</au><au>Thornburg, Natalie J</au><au>Bangaru, Sandhya</au><au>Kose, Nurgun</au><au>Finn, Jessica A</au><au>Bombardi, Robin</au><au>Soto, Cinque</au><au>Chen, Elaine C</au><au>Nargi, Rachel S</au><au>Sutton, Rachel E</au><au>Irving, Ryan P</au><au>Suryadevara, Naveenchandra</au><au>Westover, Jonna B</au><au>Carnahan, Robert H</au><au>Turner, Hannah L</au><au>Li, Sheng</au><au>Ward, Andrew B</au><au>Crowe, Jr, James E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>131</volume><issue>15</issue><spage>1</spage><epage>11</epage><pages>1-11</pages><issn>1558-8238</issn><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>Broadly reactive antibodies targeting the influenza A virus hemagglutinin (HA) head domain are thought to be rare and to require extensive somatic mutations or unusual structural features to achieve breadth against divergent HA subtypes. Here we describe common genetic and structural features of protective human antibodies from several individuals recognizing the trimer interface (TI) of the influenza A HA head, a recently identified site of vulnerability. We examined the sequence of TI-reactive antibodies, determined crystal structures for TI antibody-antigen complexes, and analyzed the contact residues of the antibodies on HA to discover common genetic and structural features of TI antibodies. Our data reveal that many TI antibodies are encoded by a light chain variable gene segment incorporating a shared somatic mutation. In addition, these antibodies have a shared acidic residue in the heavy chain despite originating from diverse heavy chain variable gene segments. These studies show that the TI region of influenza A HA is a major antigenic site with conserved structural features that are recognized by a common human B cell public clonotype. The canonical nature of this antibody-antigen interaction suggests that the TI epitope might serve as an important target for structure-based vaccine design.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>34156974</pmid><doi>10.1172/JCI146791</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-3523-3616</orcidid><orcidid>https://orcid.org/0000-0002-3642-2980</orcidid><orcidid>https://orcid.org/0000-0002-4745-8057</orcidid><orcidid>https://orcid.org/0000-0001-7153-3769</orcidid><orcidid>https://orcid.org/0000-0003-2571-1290</orcidid><orcidid>https://orcid.org/0000-0001-6712-5076</orcidid><orcidid>https://orcid.org/0000-0001-7883-8039</orcidid><orcidid>https://orcid.org/0000-0002-9073-6809</orcidid><orcidid>https://orcid.org/0000-0003-4542-7756</orcidid><orcidid>https://orcid.org/0000-0002-0049-1079</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1558-8238
ispartof The Journal of clinical investigation, 2021-08, Vol.131 (15), p.1-11
issn 1558-8238
0021-9738
1558-8238
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8321569
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Antibodies
Antibodies, Neutralizing - chemistry
Antibodies, Neutralizing - immunology
Antibodies, Viral - chemistry
Antibodies, Viral - immunology
Antigen-antibody reactions
Antigens
Avian flu
Biomedical research
Development and progression
Epitopes
Epitopes - chemistry
Epitopes - immunology
Genetic aspects
Genetic diversity
Glycoproteins
Health aspects
Hemagglutinin Glycoproteins, Influenza Virus - chemistry
Hemagglutinin Glycoproteins, Influenza Virus - immunology
Hemagglutinins
Humans
Immunization
Immunological research
Influenza
Influenza A
Influenza A Virus, H1N1 Subtype - chemistry
Influenza A Virus, H1N1 Subtype - immunology
Influenza vaccines
Influenza Vaccines - chemistry
Influenza Vaccines - immunology
Mutation
Peptides
Prevention
Structure
Trimers
Vaccines
Viral antibodies
Viral proteins
Viruses
title Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A26%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Canonical%20features%20of%20human%20antibodies%20recognizing%20the%20influenza%20hemagglutinin%20trimer%20interface&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Zost,%20Seth%20J&rft.date=2021-08-01&rft.volume=131&rft.issue=15&rft.spage=1&rft.epage=11&rft.pages=1-11&rft.issn=1558-8238&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI146791&rft_dat=%3Cgale_pubme%3EA677389416%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2557557663&rft_id=info:pmid/34156974&rft_galeid=A677389416&rfr_iscdi=true